MiniMed Group, Inc. MMED recently announced results from a new randomized crossover study showing that glycemic outcomes ...

PHILADELPHIA -- Artificial intelligence is helping Temple Health prevent patients with diabetes from experiencing dangerous swings in their blood sugar levels, administrators say. The North ...

Twenty-four adult participants with type 1 diabetes were randomized to use either the Simplera Sync™ or Instinct sensor for a six-week period, then crossed over to the alternate sensor for an ...

TheFly reported on May 7 that AMLX reported first-quarter 2026 results for the period ended March 31, 2026, alongside ...

Advanced diabetes technology like CGM systems and insulin pumps can help you manage blood sugar fluctuations and make smarter ...

Emergency medicine (EM) has always been subject to payer scrutiny, but today’s reimbursement pressure is different: it is ...

Summer is a time when many people travel to unique and beautiful places. However, for individuals living with diabetes, travel can create additional challenges in managing blood glucose […] ...

Adults with T1D who receive GLP-1-based therapy may have a lower risk for adverse cardiovascular outcomes and no significant ...

By Nick Gunn and Courtney Rogers University of Kentucky Summer is a time when many people travel to unique and beautiful places. But for individuals living with diabetes, travel can create additional ...

Participation, retention, and treatment duration in the open-label extension (OLE) following the completions of the study is high and has resulted in continued glycemic benefit, concurrent with the ...

Consolidated net revenue of € 713.4 million in the first quarter of 2026, +4.9% or +8.7% on a like-for-like basis(3) at constant exchange rates ...